Global POC Diagnostics Market Growth 2025-2031

Publication ID:

LPI07251387

Publication Date:

July 1, 2025

Pages:

128

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global POC Diagnostics market size is predicted to grow from US$ 32550 million in 2025 to US$ 56890 million in 2031; it is expected to grow at a CAGR of 9.8% from 2025 to 2031.
Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
In United States, POC Diagnostics key players include Alere, Roche, Abbott Laboratories, Johnson & Johnson, etc. Global top four manufacturers hold a share over 50%.
In terms of product, Blood Glucose Testing is the largest segment, with a share over 45%. And in terms of application, the largest application is Clinics, followed by Hospitals, Laboratory, etc.
The 鈥淧OC Diagnostics Industry Forecast鈥� looks at past sales and reviews total world POC Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected POC Diagnostics sales for 2025 through 2031. With POC Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POC Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global POC Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on POC Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global POC Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POC Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POC Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of POC Diagnostics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas or Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
Segmentation by Application:
Clinics
Hospitals
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global POC Diagnostics market?
What factors are driving POC Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do POC Diagnostics market opportunities vary by end market size?
How does POC Diagnostics break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global POC Diagnostics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for POC Diagnostics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for POC Diagnostics by Country/Region, 2020, 2024 & 2031
2.2 POC Diagnostics Segment by Type
2.2.1 Blood Glucose Testing
2.2.2 Infectious Diseases Testing
2.2.3 Cardiac Markers Testing
2.2.4 Coagulation Testing
2.2.5 Pregnancy and Fertility Testing
2.2.6 Blood Gas or Electrolytes Testing
2.2.7 Tumor Markers Testing
2.2.8 Urinalysis Testing
2.2.9 Cholesterol Testing
2.3 POC Diagnostics Sales by Type
2.3.1 Global POC Diagnostics Sales Market Share by Type (2020-2025)
2.3.2 Global POC Diagnostics Revenue and Market Share by Type (2020-2025)
2.3.3 Global POC Diagnostics Sale Price by Type (2020-2025)
2.4 POC Diagnostics Segment by Application
2.4.1 Clinics
2.4.2 Hospitals
2.4.3 Laboratory
2.4.4 Others
2.5 POC Diagnostics Sales by Application
2.5.1 Global POC Diagnostics Sale Market Share by Application (2020-2025)
2.5.2 Global POC Diagnostics Revenue and Market Share by Application (2020-2025)
2.5.3 Global POC Diagnostics Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global POC Diagnostics Breakdown Data by Company
3.1.1 Global POC Diagnostics Annual Sales by Company (2020-2025)
3.1.2 Global POC Diagnostics Sales Market Share by Company (2020-2025)
3.2 Global POC Diagnostics Annual Revenue by Company (2020-2025)
3.2.1 Global POC Diagnostics Revenue by Company (2020-2025)
3.2.2 Global POC Diagnostics Revenue Market Share by Company (2020-2025)
3.3 Global POC Diagnostics Sale Price by Company
3.4 Key Manufacturers POC Diagnostics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers POC Diagnostics Product Location Distribution
3.4.2 Players POC Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for POC Diagnostics by Geographic Region
4.1 World Historic POC Diagnostics Market Size by Geographic Region (2020-2025)
4.1.1 Global POC Diagnostics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global POC Diagnostics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic POC Diagnostics Market Size by Country/Region (2020-2025)
4.2.1 Global POC Diagnostics Annual Sales by Country/Region (2020-2025)
4.2.2 Global POC Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas POC Diagnostics Sales Growth
4.4 APAC POC Diagnostics Sales Growth
4.5 Europe POC Diagnostics Sales Growth
4.6 Middle East & Africa POC Diagnostics Sales Growth
5 Americas
5.1 Americas POC Diagnostics Sales by Country
5.1.1 Americas POC Diagnostics Sales by Country (2020-2025)
5.1.2 Americas POC Diagnostics Revenue by Country (2020-2025)
5.2 Americas POC Diagnostics Sales by Type (2020-2025)
5.3 Americas POC Diagnostics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC POC Diagnostics Sales by Region
6.1.1 APAC POC Diagnostics Sales by Region (2020-2025)
6.1.2 APAC POC Diagnostics Revenue by Region (2020-2025)
6.2 APAC POC Diagnostics Sales by Type (2020-2025)
6.3 APAC POC Diagnostics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe POC Diagnostics by Country
7.1.1 Europe POC Diagnostics Sales by Country (2020-2025)
7.1.2 Europe POC Diagnostics Revenue by Country (2020-2025)
7.2 Europe POC Diagnostics Sales by Type (2020-2025)
7.3 Europe POC Diagnostics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa POC Diagnostics by Country
8.1.1 Middle East & Africa POC Diagnostics Sales by Country (2020-2025)
8.1.2 Middle East & Africa POC Diagnostics Revenue by Country (2020-2025)
8.2 Middle East & Africa POC Diagnostics Sales by Type (2020-2025)
8.3 Middle East & Africa POC Diagnostics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of POC Diagnostics
10.3 Manufacturing Process Analysis of POC Diagnostics
10.4 Industry Chain Structure of POC Diagnostics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 POC Diagnostics Distributors
11.3 POC Diagnostics Customer
12 World Forecast Review for POC Diagnostics by Geographic Region
12.1 Global POC Diagnostics Market Size Forecast by Region
12.1.1 Global POC Diagnostics Forecast by Region (2026-2031)
12.1.2 Global POC Diagnostics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global POC Diagnostics Forecast by Type (2026-2031)
12.7 Global POC Diagnostics Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Alere
13.1.1 Alere Company Information
13.1.2 Alere POC Diagnostics Product Portfolios and Specifications
13.1.3 Alere POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Alere Main Business Overview
13.1.5 Alere Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche POC Diagnostics Product Portfolios and Specifications
13.2.3 Roche POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories POC Diagnostics Product Portfolios and Specifications
13.3.3 Abbott Laboratories POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson POC Diagnostics Product Portfolios and Specifications
13.4.3 Johnson & Johnson POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Siemens Healthcare
13.5.1 Siemens Healthcare Company Information
13.5.2 Siemens Healthcare POC Diagnostics Product Portfolios and Specifications
13.5.3 Siemens Healthcare POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Siemens Healthcare Main Business Overview
13.5.5 Siemens Healthcare Latest Developments
13.6 Danaher
13.6.1 Danaher Company Information
13.6.2 Danaher POC Diagnostics Product Portfolios and Specifications
13.6.3 Danaher POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Danaher Main Business Overview
13.6.5 Danaher Latest Developments
13.7 Bayer Healthcare
13.7.1 Bayer Healthcare Company Information
13.7.2 Bayer Healthcare POC Diagnostics Product Portfolios and Specifications
13.7.3 Bayer Healthcare POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Bayer Healthcare Main Business Overview
13.7.5 Bayer Healthcare Latest Developments
13.8 Beckman Coulter
13.8.1 Beckman Coulter Company Information
13.8.2 Beckman Coulter POC Diagnostics Product Portfolios and Specifications
13.8.3 Beckman Coulter POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Beckman Coulter Main Business Overview
13.8.5 Beckman Coulter Latest Developments
13.9 Nipro Diagnostics
13.9.1 Nipro Diagnostics Company Information
13.9.2 Nipro Diagnostics POC Diagnostics Product Portfolios and Specifications
13.9.3 Nipro Diagnostics POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Nipro Diagnostics Main Business Overview
13.9.5 Nipro Diagnostics Latest Developments
13.10 Bio-Rad Laboratories
13.10.1 Bio-Rad Laboratories Company Information
13.10.2 Bio-Rad Laboratories POC Diagnostics Product Portfolios and Specifications
13.10.3 Bio-Rad Laboratories POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bio-Rad Laboratories Main Business Overview
13.10.5 Bio-Rad Laboratories Latest Developments
13.11 Nova Biomedical
13.11.1 Nova Biomedical Company Information
13.11.2 Nova Biomedical POC Diagnostics Product Portfolios and Specifications
13.11.3 Nova Biomedical POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Nova Biomedical Main Business Overview
13.11.5 Nova Biomedical Latest Developments
13.12 BioMerieux
13.12.1 BioMerieux Company Information
13.12.2 BioMerieux POC Diagnostics Product Portfolios and Specifications
13.12.3 BioMerieux POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 BioMerieux Main Business Overview
13.12.5 BioMerieux Latest Developments
13.13 Quidel
13.13.1 Quidel Company Information
13.13.2 Quidel POC Diagnostics Product Portfolios and Specifications
13.13.3 Quidel POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Quidel Main Business Overview
13.13.5 Quidel Latest Developments
13.14 Helena Laboratories
13.14.1 Helena Laboratories Company Information
13.14.2 Helena Laboratories POC Diagnostics Product Portfolios and Specifications
13.14.3 Helena Laboratories POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Helena Laboratories Main Business Overview
13.14.5 Helena Laboratories Latest Developments
13.15 OraSure Technologies
13.15.1 OraSure Technologies Company Information
13.15.2 OraSure Technologies POC Diagnostics Product Portfolios and Specifications
13.15.3 OraSure Technologies POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 OraSure Technologies Main Business Overview
13.15.5 OraSure Technologies Latest Developments
13.16 Accriva
13.16.1 Accriva Company Information
13.16.2 Accriva POC Diagnostics Product Portfolios and Specifications
13.16.3 Accriva POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Accriva Main Business Overview
13.16.5 Accriva Latest Developments
13.17 Abaxis
13.17.1 Abaxis Company Information
13.17.2 Abaxis POC Diagnostics Product Portfolios and Specifications
13.17.3 Abaxis POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Abaxis Main Business Overview
13.17.5 Abaxis Latest Developments
13.18 Chembio Diagnostics
13.18.1 Chembio Diagnostics Company Information
13.18.2 Chembio Diagnostics POC Diagnostics Product Portfolios and Specifications
13.18.3 Chembio Diagnostics POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Chembio Diagnostics Main Business Overview
13.18.5 Chembio Diagnostics Latest Developments
13.19 Trinity Biotech
13.19.1 Trinity Biotech Company Information
13.19.2 Trinity Biotech POC Diagnostics Product Portfolios and Specifications
13.19.3 Trinity Biotech POC Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Trinity Biotech Main Business Overview
13.19.5 Trinity Biotech Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂